Medications Updated During 2014, From Newest to Oldest, Page 3

Page 3 of 330 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

Carvedilol

Carvedilol Tablet is an alpha/beta-adrenergic blocking agent indicated for the treatment of: Left ventricular dysfunction following myocardial infarction in clinically stable patients (1.2) Hypertension (1.3) 1.2 Left Ventricular Dysfunction…

State of Florida DOH Central Pharmacy29 December 2014

Carbamazepine

Carbamazepine is indicated for use as an anticonvulsant drug. Evidence supporting efficacy of carbamazepine as an anticonvulsant was derived from active drug-controlled studies that enrolled patients with the following seizure types: 1. Partial…

State of Florida DOH Central Pharmacy29 December 2014

Maprotiline Hydrochloride

Maprotiline hydrochloride tablets are indicated for the treatment of depressive illness in patients with depressive neurosis (dysthymic disorder) and manic depressive illness, depressed…

Mylan Pharmaceuticals Inc.25 December 2014

Escitalopram Oxalate (Escitalopram)

Escitalopram oral solution USP is a selective serotonin reuptake inhibitor (SSRI) indicated for: Acute and Maintenance Treatment of Major Depressive Disorder (MDD) in adults and adolescents aged 12 to 17 years (1.1) Acute Treatment of Generalized…

Amneal Pharmaceuticals of New York, LLC24 December 2014

Timolol Maleate

Timolol Maleate Ophthalmic Gel Forming Solution is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. CONTRAINDICATIONS: Timolol Maleate Ophthalmic Gel Forming Solution is…

Aton Pharma, Inc.23 December 2014

Page 3 of 330 « 1 2 3 4 5 … 10 15 20 25 30 … » Last Page »

FDA Medwatch

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets
Tue, 07 Jul 2020. As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard® Infusion Pump Systems, the company conducted additional flow-rate accuracy testing. This testing revealed that some…
Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg Due to the Detection of N-Nitrosodimethylamine (NDMA) Impurity
Tue, 07 Jul 2020. Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA,…

MedLibrary.org

Medication Sections

RSS Feeds

About

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.